Clinical trial
Vaccination With Tetanus and KLH to Assess Immune Responses.
NCT00000105 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00000105 |
|---|---|
| Title | Vaccination With Tetanus and KLH to Assess Immune Responses. |
| Official title | Vaccination With Tetanus Toxoid and Keyhole Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Cancer |
| Intervention type | Biological, Drug |
| Interventions | Intracel KLH Vaccine, Biosyn KLH, Montanide ISA51, Tetanus toxoid |
| Enrollment | 112 |
| Start date | Jul 1, 2002 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Nov 4, 1999 |
| Last update posted | Nov 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: